These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28795320)

  • 21. [Expressions of EZH2 and RUNX3 in renal cell carcinoma and their clinical significance].
    Wang G; Qin W; Zheng J; Wei M; Zhou X; Wang H; Wen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):82-4, 88. PubMed ID: 23294722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA SOX2-OT facilitates laryngeal squamous cell carcinoma development by epigenetically inhibiting PTEN via methyltransferase EZH2.
    Tai Y; Ji Y; Liu F; Zang Y; Xu D; Ma S; Qin L; Ma J
    IUBMB Life; 2019 Sep; 71(9):1230-1239. PubMed ID: 30811870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic network of EZH2/SFRP1/Wnt in the epithelial-mesenchymal transition of laryngeal carcinoma cells.
    Chen W; Wang HT; Ji JF; Wang ZY; Shi T; Wu MH; Yu PJ
    Neoplasma; 2022 May; 69(3):680-690. PubMed ID: 35400167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperoxia-induced methylation decreases RUNX3 in a newborn rat model of bronchopulmonary dysplasia.
    Zhu Y; Fu J; Yang H; Pan Y; Yao L; Xue X
    Respir Res; 2015 Jun; 16(1):75. PubMed ID: 26104385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
    Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
    Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
    [No Abstract]   [Full Text] [Related]  

  • 28. GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers.
    Ko HW; Lee HH; Huo L; Xia W; Yang CC; Hsu JL; Li LY; Lai CC; Chan LC; Cheng CC; Labaff AM; Liao HW; Lim SO; Li CW; Wei Y; Nie L; Yamaguchi H; Hung MC
    Oncotarget; 2016 Aug; 7(35):57131-57144. PubMed ID: 27494834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EZH2 Impairs Human Dental Pulp Cell Mineralization via the Wnt/β-Catenin Pathway.
    Li B; Yu F; Wu F; Hui T; A P; Liao X; Yin B; Wang C; Ye L
    J Dent Res; 2018 May; 97(5):571-579. PubMed ID: 29294297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
    Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
    Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-600 mediates EZH2/RUNX3 signal axis to modulate breast cancer cell viability and sorafenib sensitivity.
    Zhao Q; Li D; Feng J; Jinsihan D
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23613. PubMed ID: 38229326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription.
    Li Q; Li B; Dong C; Wang Y; Li Q
    Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
    Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
    Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of EZH2 by RNA interference inhibits proliferation and invasion of ACHN cells via the Wnt/β- catenin pathway.
    Yuan JB; Yang LY; Tang ZY; Zu XB; Qi L
    Asian Pac J Cancer Prev; 2012; 13(12):6197-201. PubMed ID: 23464430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal.
    Zhu P; Wang Y; Huang G; Ye B; Liu B; Wu J; Du Y; He L; Fan Z
    Nat Struct Mol Biol; 2016 Jul; 23(7):631-9. PubMed ID: 27239797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.
    Wang Y; Wang M; Wei W; Han D; Chen X; Hu Q; Yu T; Liu N; You Y; Zhang J
    Oncotarget; 2016 Aug; 7(31):49450-49458. PubMed ID: 27385092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
    Yang F; Lv LZ; Cai QC; Jiang Y
    World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and therapeutic significance of EZH2 in urological cancers.
    Liu X; Wu Q; Li L
    Oncotarget; 2017 Jun; 8(23):38044-38055. PubMed ID: 28410242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.
    Chen JF; Luo X; Xiang LS; Li HT; Zha L; Li N; He JM; Xie GF; Xie X; Liang HJ
    Oncotarget; 2016 Jul; 7(27):41540-41558. PubMed ID: 27172794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.